Xenon Pharmaceuticals Inc. Forecast and Stock Analysis
Technical XENE stock analysis for Thursday May 23, 2019.
|Price to book||USD 3.02|
|Next Earnings Date||2019-08-07|
Xenon Pharmaceuticals Inc. fell by -1.52% in the last day ( Thursday, 23rd May 2019 ) from $9.90 to $9.75 During day the stock fluctuated 7.20% from a day low at $9.50 to a day high of $10.18. The price has risen in 5 of the last 10 days and is up by 4.95% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -15 059 shares and in total 57 852 shares bought and sold for approximately $564 057.00.
- 30 day high of the XENE stock price was $10.27 and low was $8.59.
- 90 day high was $10.74 and low was $7.58.
- 52 week high for the Xenon Pharmaceuticals Inc. - $15.92 and low - $5.25.
Given the current horizontal trend you can expect Xenon Pharmaceuticals Inc. with 90% probability to be traded between $8.72 and $10.72 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Xenon Pharmaceuticals Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $9.55 and $9.37. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday May 22, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 57 and the stock is currently not being overbought or oversold
Support & Resistance
Xenon Pharmaceuticals Inc. finds support from accumulated volume at $9.30.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stoploss: $9.28 (-4.83%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 days ago.)
6.93 %Average volatility
Very Low Low Medium High Very High
Xenon Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|XENE $9.75 ($-0.15 -1.52%)|
XENE is down $0.15 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for XENE based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the XENE analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us